LEXICON PHARMACEUTICALS INC's ticker is LXRX and the CUSIP is 528872302. A total of 106 filers reported holding LEXICON PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 1.12 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $9,204,000 | +28.1% | 1,463,262 | +13.2% | 0.01% | +33.3% |
| Q1 2019 | $7,184,000 | -13.4% | 1,292,130 | +3.4% | 0.01% | -25.0% |
| Q4 2018 | $8,297,000 | -40.0% | 1,249,590 | -3.6% | 0.01% | -33.3% |
| Q3 2018 | $13,827,000 | +691250.0% | 1,295,910 | +974268.4% | 0.01% | – |
| Q2 2018 | $2,000 | +100.0% | 133 | +9.0% | 0.00% | – |
| Q1 2018 | $1,000 | 0.0% | 122 | 0.0% | 0.00% | – |
| Q4 2017 | $1,000 | -96.8% | 122 | -95.2% | 0.00% | – |
| Q3 2017 | $31,000 | -16.2% | 2,554 | +13.6% | 0.00% | – |
| Q2 2017 | $37,000 | +42.3% | 2,249 | +22.4% | 0.00% | – |
| Q1 2017 | $26,000 | – | 1,837 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ulys, L.L.C. | 4,321,214 | $14,779,000 | 100.00% |
| Artal Group S.A. | 71,178,364 | $243,430,000 | 5.23% |
| BVF INC/IL | 10,963,000 | $37,493,000 | 1.48% |
| Integral Health Asset Management, LLC | 300,000 | $1,026,000 | 0.30% |
| NEA Management Company, LLC | 2,382,286 | $8,147,000 | 0.22% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 35,714 | $122,000 | 0.13% |
| PINNACLE ASSOCIATES LTD | 1,852,382 | $6,335,000 | 0.13% |
| XTX MARKETS LLC | 13,242 | $45,000 | 0.09% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 828,192 | $2,832,000 | 0.06% |
| WINTON GROUP Ltd | 192,890 | $660,000 | 0.05% |